Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study

被引:0
|
作者
Yiannakou, Ioanna [1 ]
Long, Michelle T. [2 ,3 ]
Jacques, Paul F. [4 ]
Beiser, Alexa [5 ,6 ]
Pickering, Richard T. [1 ]
Moore, Lynn L. [1 ]
机构
[1] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med Prevent Med & Epidemiol, Boston, MA 02118 USA
[2] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med, Sect Gastroenterol, Boston, MA USA
[3] Novo Nordisk, Vandtarnsvej 108-110, Soborg, Denmark
[4] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Epidemiol, Boston, MA USA
[5] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[6] Boston Univ, Chobanian & Avedisian Sch Med, Dept Neurol, Boston, MA USA
来源
JOURNAL OF NUTRITION | 2025年 / 155卷 / 03期
关键词
eggs; dietary choline; lutein; zeaxanthin; liver fat; nonalcoholic fatty liver disease; PLASMA CAROTENOID CONCENTRATIONS; FOOD-FREQUENCY QUESTIONNAIRE; CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR RISK; HEPATIC STEATOSIS; CONSUMPTION; METABOLISM; BETAINE; PHOSPHATIDYLCHOLINE; INFLAMMATION;
D O I
10.1016/j.tjnut.2024.10.026
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Eggs are rich in bioactive compounds, including choline and carotenoids that may benefit cardiometabolic outcomes. However, little is known about their relationship with nonalcoholic fatty liver disease (NAFLD). Objectives: We investigated the association between intakes of eggs and selected egg-rich nutrients (choline, lutein, and zeaxanthin) and NAFLD risk and changes in liver fat over similar to 6 y of follow-up in the Framingham Offspring and Third Generation cohorts. Methods: On 2 separate occasions (2002-2005 and 2008-2011), liver fat was assessed using a computed tomography scan to estimate the average liver fat attenuation relative to a control phantom to create the liver phantom ratio (LPR). In 2008-2011, cases of incident NAFLD were identified as an LPR <= 0.33 in the absence of heavy alcohol use, after excluding prevalent NAFLD (LPR <= 0.33) in 2002-2005. Food frequency questionnaires were used to estimate egg intakes (classified as <1, 1, and >= 2 per week), dietary choline (adjusted for body weight using the residual method), and the combined intakes of lutein and zeaxanthin. Multivariable modified Poisson regression and general linear models were used to compute incident risk ratios (RR) of NAFLD and adjusted mean annualized liver fat change. Results: NAFLD cumulative incidence was 19% among a total of 1414 participants. We observed no associations between egg intake or the combined intakes of lutein and zeaxanthin with an incident NAFLD risk or liver fat change. Other diet and cardiometabolic risk factors did not modify the association between egg intake and NAFLD risk. However, dietary choline intakes were inversely associated with NAFLD risk (RR for tertile 3 compared with tertile 1: 0.69, 95% CI: 0.51, 0.94). Conclusions: Although egg intake was not directly associated with NAFLD risk, eggs are a major source of dietary choline, which was strongly inversely associated with NAFLD risk in this community-based cohort.
引用
收藏
页码:923 / 935
页数:13
相关论文
共 50 条
  • [1] Nonalcoholic Fatty Liver Disease Associates with Cardiovascular Disease Outcomes: The Framingham Heart Study
    Mellinger, Jessica
    Pencina, Karol M.
    Massaro, Joseph M.
    Hoffmann, Udo
    Seshadri, Sudha
    Fox, Caroline S.
    O'Donnell, Christopher J.
    Speliotes, Elizabeth K.
    HEPATOLOGY, 2013, 58 : 484A - 485A
  • [2] The Framingham risk score and heart disease in nonalcoholic fatty liver disease
    Treeprasertsuk, Sombat
    Leverage, Scott
    Adams, Leon A.
    Lindor, Keith D.
    St Sauver, Jennifer
    Angulo, Paul
    LIVER INTERNATIONAL, 2012, 32 (06) : 945 - 950
  • [3] Nonalcoholic Fatty Liver Disease and Vascular Function Cross-Sectional Analysis in the Framingham Heart Study
    Long, Michelle T.
    Wang, Na
    Larson, Martin G.
    Mitchell, Gary F.
    Palmisano, Joseph
    Vasan, Ramachandran S.
    Hoffmann, Udo
    Speliotes, Elizabeth K.
    Vita, Joseph A.
    Benjamin, Emelia J.
    Fox, Caroline S.
    Hamburg, Naomi M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (05) : 1284 - 1291
  • [4] Dietary composition and nonalcoholic fatty liver disease
    Solga, S
    Alkhuraishe, AR
    Clark, JM
    Torbenson, M
    Greenwald, A
    Diehl, AM
    Magnuson, T
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (10) : 1578 - 1583
  • [5] Dietary Composition and Nonalcoholic Fatty Liver Disease
    Steven Solga
    Amir R. Alkhuraishe
    Jeanne M. Clark
    Mike Torbenson
    Ashli Greenwald
    Anna Mae Diehl
    Thomas Magnuson
    Digestive Diseases and Sciences, 2004, 49 : 1578 - 1583
  • [6] Dietary fructose in nonalcoholic fatty liver disease
    Vos, Miriam B.
    Lavine, Joel E.
    HEPATOLOGY, 2013, 57 (06) : 2525 - 2531
  • [7] Dietary approaches to managing nonalcoholic fatty liver disease
    El Khoury, Dalia
    Pauley, Rosemary J.
    Berseth, Carol Lynn
    NURSE PRACTITIONER, 2021, 46 (02): : 19 - 26
  • [8] Dietary approach in the treatment of nonalcoholic fatty liver disease
    Ferolla, Silvia Marinho
    Silva, Luciana Costa
    Abreu Ferrari, Maria de Lourdes
    da Cunha, Aloisio Sales
    Martins, Flaviano dos Santos
    Couto, Claudia Alves
    Abreu Ferrari, Teresa Cristina
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (24) : 2522 - 2534
  • [9] Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
    Jeznach-Steinhagen, Anna
    Ostrowska, Joanna
    Czerwonogrodzka-Senczyna, Aneta
    Boniecka, Iwona
    Shahnazaryan, Urszula
    Kurylowicz, Alina
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [10] Dietary recommendations for patients with nonalcoholic fatty liver disease
    Kargulewicz, Angelika
    Stankowiak-Kulpa, Hanna
    Grzymislawski, Marian
    PRZEGLAD GASTROENTEROLOGICZNY, 2014, 9 (01): : 18 - 23